Rouz Darou Pharmaceutical Company (DARUZ) income statement
Operating revenue through to net profit and earnings per share
- Ticker
- DARUZ
- Industry
- Pharmaceuticals
- Market
- Tehran Stock Exchange
Latest periods
| Item | To 1405/06/31 | To 1404/06/31 | To 1403/06/31 | To 1402/06/31 | To 1401/06/31 | To 1400/06/31 |
|---|---|---|---|---|---|---|
| Operating revenue | 7,519,282 | 2,252,781 | 2,530,991 | 4,201,758 | 1,826,766 | 946,713 |
| Cost of operating revenue | -2,619,516 | -2,030,236 | -2,420,440 | -2,811,253 | -1,446,617 | -605,581 |
| Gross profit (loss) | 4,899,766 | 222,545 | 110,551 | 1,390,505 | 380,149 | 341,132 |
| Selling, general and administrative expenses | -453,558 | -179,003 | -260,041 | -246,536 | -93,043 | -126,005 |
| Other income | 34,618 | 168,746 | 922 | 1,248 | 5,317 | 45,222 |
| Other expenses | -965,957 | 0 | -1,317 | -44,057 | -11,278 | -34,972 |
| Operating profit (loss) | 3,514,869 | 212,288 | -149,885 | 1,101,160 | 281,145 | 225,377 |
| Finance costs | -998,697 | -586,061 | -943,964 | -602,056 | -270,611 | -185,864 |
| Other non-operating income and expenses | 18,423 | 33,285 | 9,640 | 24,201 | 4,557 | 6,099 |
| Profit (loss) from continuing operations before tax | 2,534,595 | -340,488 | -1,084,209 | 523,305 | 15,091 | 45,612 |
| Current year tax | -446,546 | 0 | 0 | -67,617 | -2,379 | -6,396 |
| Net profit (loss) from continuing operations | 2,088,049 | -340,488 | -1,084,209 | 455,688 | 12,712 | 39,216 |
| Net profit (loss) | 2,088,049 | -340,488 | -1,084,209 | 455,688 | 12,712 | 39,216 |
| Basic earnings (loss) per share | 1,779 rials | -243 rials | 0 rials | 651 rials | 19 rials | 56 rials |
| Net earnings (loss) per share, rials | 1,492 rials | -243 rials | -774 rials | 652 rials | 19 rials | 57 rials |
| Capital | 1,399,680 | 1,399,680 | 1,399,680 | 699,840 | 699,840 | 699,840 |
Reporting periods
87 periods are on file for this report, from the period ending 1387/12/30 to the period ending 1405/06/31.